Lecture 10: Dementia 1 Flashcards

(48 cards)

1
Q

Crystallized intelligence

A

Skills, abilities and knowledge that are overlearned, well-practiced and familiar.
Vocabulary and general knowledge

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Fluid intelligence

A

Abilities involving problem-solving and reasoning
Processing speed and executive functions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cognitive changes in normal cognitive aging

A

Declined fluid intelligence and intact or improved crystallized intelligence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Types of memory that decline with age

A
  1. Spontaneous retrieval: without cues
  2. Source memory: where is the information from
  3. Prospective memory: rmb to do smth in future
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Types of memory remains stable with age

A
  1. Recognition memory: rmb events when given cues
  2. Temporal order memory: sequence of past events
  3. Procedural memory: rmb how to do thing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Structural and functional changes in normal cognitive aging

A
  1. thinner cortical and decreased gray matter
  2. decreased white matter density (especially frontal and occipital)
  3. loss of dopamine receptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

protective factors for successful cognitive aging

A
  1. Life style
    - active and healthy lifestyle
    - cognitive and social stimulation
    - limit cardiovascular risk
  2. Cognitive reserve
    - plasticity
    - level of education
  3. Cognitive retraining
    - teaching strategies to improve memory, reasoning and speed of processing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

dementia

A

the umbrella term for a number of neurological conditions, of which the major symptom is the decline in cognitive function due to physical changes in the brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

main difference between minor (mild cognitive impairment) and major (dementia) neurocognitive disorders

A

ability to function independently
1-2 standard deviations below mean in cognitive assessment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

minor neurocognitive disorders

A

mild cognitive impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MCI = precursor (tien than) of

A

all forms of neurodegenerative diseases
However, A proportion of people with MCI do not have
an underlying neurodegenerative disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

The chance to develop dementia within 5 to
10 years after MCI diagnosis is on average
about

A

50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Treatment for MCI

A

no intervention
-> reassessment, psychoedu and cognitive training

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

major neurocognitive disorders

A
  • significant decline
  • > 2 standard deviations below mean
  • disrupting daily function independence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

The clinical diagnosis of
dementia (or Major neurocognitive disorder) does
NOT say anything about its cause:

A

The etiological subtype is defined by the underlying brain pathology (Alzheimer, Vasculair, Frontotemporal)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Alzheimer’s disease (and variants)

A

a neurodegenerative disease that causes dementia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

the most common cause of dementia accounting for
about 70% of all dementia cases

A

Alzheimer’s disease (and variants)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

First and most prominant symptom is

A

gradually progressive memory loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Prognosis

A
  • As AD progresses, multiple cognitive domains become affected
  • Neuropsychiatric symptoms such as depression, apathy and anxiety are also common
  • Final stage, there is overall cognitive loss, and the person is completely dependent on their environment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Diagnosis criteria 1

A
  1. major neurocognitive disorder
  2. Vague onset and gradually progressive course (months to years)
  3. Cognitive impairment involves a minimum of two of the following domains: executive function, memory, language, visuospatial functions.
  4. No evidence of a substantial concomitant cerebrovascular, neurological or psychiatric disease that could explain the cognitive symptoms
21
Q

additional evidence

A

1, brain imaging
2. formal neuropsychological evaluation
3, Evidence of a causative Alzheimer’s disease genetic mutation (very rare)

22
Q

cause of AD

A
  1. amyloid cascade hypothesis
  2. vascular hypothesis
  3. both hypotheses combined
23
Q

amyloid cascade hypothesis

A

the abnormally accumulation (tich tu) of amyloid-beta-protein -> amyloid plaques -> disrupts the connection of neuron -> clearing amyloid plaques = therapy( remains inconclusive)

24
Q

Criticism of amyloid cascade hypothesis

A
  • Lack of coherent evidence
  • It is not yet clear whether plaques and tangles are a cause of Alzheimer’s disease or just a consequence.
  • Failure to provide an effective treatment
25
Vascular hypothesis
vascular risk factors -> lack of blood and oxygen to the brain -> metabolic reaction -> overproduction of amyloid-beta-protein
26
non-modifiable risk factors in AD
1. gender: female 2. older age 3. genetic predisposition
27
modifiable risk factor in AD
life style,...
28
Clinical course of AD can be divided into the following stages
1. MCI 2. Mild dementia 3. Moderate dementia 4. Severe dementia
29
Most reported cognitive complaints that patients initially present with are:
- Difficulty remembering recent events - Forgetting appointments - Word-finding problems
30
assess the clinical stage of AD
Clinical Dementia Rating (CDR) – semi structured interview
31
Mild dementia (CDR1)
Ø problems in other cognitive functions start to emerge: language production, orientation in time and place, planning and performing activities. Ø Leading to clear limitations in daily life
32
Moderate Dementia
- More extensive cognitive impairments occur - Person becomes increasingly dependent on others in daily life - Basic activities of daily living such as dressing, become more difficult
32
Severe Dementia (CDR3)
Ø Final stage Ø Completely dependent Ø Confused Ø Incontinent (involuntary mat kiem soat)
33
Brain in EEG
slowing of alpha activity
33
Brain changes in AD (CT & MRI)
- extremely reduced cerebral cortex - severely enlarged ventricles - extremely reduced hippocampus
34
PET scan
reduced glucose absorption (metabolized)
35
Clinical diagnosis for AD
Diagnostic cycle 4 stages
36
1.Complaints analysis
Both with patient and close relative: * Reduced insight into deficits (anosognosia) * Patients with dementia/AD commonly deny or trivialise their complaints * Ask questions about: * Subjective complaints of cognitive dysfunctions (e.g., memory, concentration etc.) * Onset and progression of the cognitive problems * Psychiatric symptoms (e.g., mood and anxiety) * Level of independence (activities of daily functioning) * Assessment of global cognitive functioning with screening test (e.g., MMSE) * Family and medical history * Medication use
37
anosognosia
Reduced insight into deficits
38
2.Problem analysis
Neuropsychological assessment
39
Memory (declarative episodic memory)
Early stages: typically anterograde long-term memory impairment * Later stages: also retrograde memory impairment and semantic memory problems
40
Executive function and problem solving
Cognitive flexibility and planning problems
41
Attention
Mental flexibility and divided attention problems (switch task and multitasking)
42
Other symptoms
* Olfactory dysfunction * Seizures (10-20% of cases, usually in later stages of disease) * Motor signs (typically in later stages of disease)
43
Treatment options
Alzheimer's disease cannot be cured Medication to inhibit cognitive symptoms to a certain extent: - Cholinesterase inhibitors for patients with mild to moderate AD) - Memantine (N-Methyl D-aspartate antagonist) for patients with moderate to severe AD * Psychoeducation * Cognitive training (early stages) * Manage behavioral symptoms
44
Prevalence and incidence of AD are
prevalence -> increasing (aging population) incidence -> decreasing (better cardiovascular care)
45
Amyloid plaques can appear
20–30 years before symptoms
46
40% of dementias may be preventable
via lifestyle changes